DE69925721D1 - Verfahren zur herstellung eines geschützten 4-aminomethyl-pyrrolidin-3-ons - Google Patents

Verfahren zur herstellung eines geschützten 4-aminomethyl-pyrrolidin-3-ons

Info

Publication number
DE69925721D1
DE69925721D1 DE69925721T DE69925721T DE69925721D1 DE 69925721 D1 DE69925721 D1 DE 69925721D1 DE 69925721 T DE69925721 T DE 69925721T DE 69925721 T DE69925721 T DE 69925721T DE 69925721 D1 DE69925721 D1 DE 69925721D1
Authority
DE
Germany
Prior art keywords
pyrrolidin
aminomethyl
protected
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925721T
Other languages
English (en)
Other versions
DE69925721T2 (de
Inventor
Yul Moon
Sup Kim
Hee Lee
Hyok Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Life Sciences Ltd filed Critical LG Life Sciences Ltd
Application granted granted Critical
Publication of DE69925721D1 publication Critical patent/DE69925721D1/de
Publication of DE69925721T2 publication Critical patent/DE69925721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69925721T 1998-03-04 1999-03-04 Verfahren zur herstellung eines geschützten 4-aminomethyl-pyrrolidin-3-ons Expired - Lifetime DE69925721T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19980007079 1998-03-04
KR7007998 1998-03-04
KR4363698 1998-10-19
KR1019980043636A KR100286874B1 (ko) 1998-03-04 1998-10-19 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
PCT/KR1999/000099 WO1999044991A1 (en) 1998-03-04 1999-03-04 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one

Publications (2)

Publication Number Publication Date
DE69925721D1 true DE69925721D1 (de) 2005-07-14
DE69925721T2 DE69925721T2 (de) 2006-03-23

Family

ID=26633492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925721T Expired - Lifetime DE69925721T2 (de) 1998-03-04 1999-03-04 Verfahren zur herstellung eines geschützten 4-aminomethyl-pyrrolidin-3-ons

Country Status (29)

Country Link
US (1) US6307059B1 (de)
EP (1) EP1068182B1 (de)
JP (1) JP3374155B2 (de)
KR (1) KR100286874B1 (de)
CN (1) CN1149192C (de)
AP (1) AP1305A (de)
AT (1) ATE297379T1 (de)
AU (1) AU742497B2 (de)
BG (1) BG64674B1 (de)
BR (1) BRPI9908472B8 (de)
CA (1) CA2322540C (de)
CZ (1) CZ301011B6 (de)
DE (1) DE69925721T2 (de)
EA (1) EA002499B1 (de)
ES (1) ES2242382T3 (de)
HU (1) HU228309B1 (de)
ID (1) ID25901A (de)
IL (1) IL137828A0 (de)
IN (1) IN190979B (de)
IS (1) IS2296B (de)
NO (1) NO317258B1 (de)
NZ (2) NZ506312A (de)
OA (1) OA11482A (de)
PT (1) PT1068182E (de)
SK (1) SK285595B6 (de)
TR (3) TR200002526T2 (de)
TW (1) TW453993B (de)
UA (1) UA71907C2 (de)
WO (1) WO1999044991A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR20020018560A (ko) * 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법
DE60229255D1 (de) * 2001-08-02 2008-11-20 Lg Life Sciences Ltd Verfahren zur herstellung von amino-geschützten 4-aminomethylene-pyrrolidin-3-on-derivaten, gemifloxacin und deren salze
RU2004112771A (ru) * 2001-09-26 2005-10-10 Байер Фармасьютикалс Корпорейшн (US) Производные 1, 8-нафтиридина как противодиабетические средства
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100515591B1 (ko) * 2003-02-12 2005-09-16 주식회사 엘지화학 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
DE102004010943A1 (de) * 2004-03-03 2005-09-29 Degussa Ag Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten
US7185495B2 (en) * 2004-09-07 2007-03-06 General Electric Company System and method for improving thermal efficiency of dry low emissions combustor assemblies
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法
CN106349083A (zh) * 2016-08-26 2017-01-25 大连奇凯医药科技有限公司 2,4,6‑三氟苯甲胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN113773240B (zh) * 2021-10-12 2022-05-31 北京阳光诺和药物研究股份有限公司 吉米沙星侧链化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309368A (en) * 1965-11-19 1967-03-14 American Cyanamid Co Substituted isoxazoles and methods of preparing the same
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
JPH0673056A (ja) * 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
EP0688772B1 (de) 1994-06-16 1999-05-06 LG Chemical Limited Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
TR200101801T2 (tr) 2002-06-21
EA002499B1 (ru) 2002-06-27
TR200002526T2 (tr) 2001-03-21
AP2000001890A0 (en) 2000-09-30
CA2322540A1 (en) 1999-09-10
IL137828A0 (en) 2001-10-31
CN1291975A (zh) 2001-04-18
EP1068182A1 (de) 2001-01-17
DE69925721T2 (de) 2006-03-23
BG104767A (en) 2001-05-31
NZ506312A (en) 2002-04-26
BR9908472B1 (pt) 2013-11-05
OA11482A (en) 2004-05-03
AU2643399A (en) 1999-09-20
US6307059B1 (en) 2001-10-23
WO1999044991A1 (en) 1999-09-10
BG64674B1 (bg) 2005-11-30
BR9908472A (pt) 2000-12-05
HUP0101094A3 (en) 2001-11-28
NZ516778A (en) 2002-12-20
NO317258B1 (no) 2004-09-27
AP1305A (en) 2004-09-10
JP2002505322A (ja) 2002-02-19
IS2296B (is) 2007-10-15
JP3374155B2 (ja) 2003-02-04
TR200101800T2 (tr) 2002-04-22
KR19990076521A (ko) 1999-10-15
NO20004288D0 (no) 2000-08-25
ATE297379T1 (de) 2005-06-15
AU742497B2 (en) 2002-01-03
BRPI9908472B8 (pt) 2021-05-25
IS5600A (is) 2000-08-22
CZ301011B6 (cs) 2009-10-14
UA71907C2 (uk) 2005-01-17
PT1068182E (pt) 2005-10-31
HU228309B1 (en) 2013-03-28
SK12992000A3 (sk) 2001-11-06
TW453993B (en) 2001-09-11
SK285595B6 (sk) 2007-04-05
CZ20003109A3 (cs) 2001-07-11
EP1068182B1 (de) 2005-06-08
CA2322540C (en) 2004-11-30
ID25901A (id) 2000-11-09
CN1149192C (zh) 2004-05-12
EA200000900A1 (ru) 2001-02-26
ES2242382T3 (es) 2005-11-01
IN190979B (de) 2003-09-06
HUP0101094A2 (hu) 2001-08-28
NO20004288L (no) 2000-10-25
KR100286874B1 (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
DE60019935D1 (de) Verfahren zur herstellung eines grundschmieröls
DE60131649D1 (de) Verfahren zur herstellung eines kristalls
DE69919742D1 (de) Verfahren zur herstellung eines bauteiles
DE60039268D1 (de) Verfahren zur Herstellung eines TFT
DE69841475D1 (de) Verfahren zur Herstellung eines MOSFET
DE60035607D1 (de) Verfahren zur herstellung eines blattförmigen waschmittels
DE69935784D1 (de) Verfahren zur herstellung eines geformten faserprodukts
DE69734843D1 (de) Verfahren zur Herstellung eines gegossenen Artikels
DE69925721D1 (de) Verfahren zur herstellung eines geschützten 4-aminomethyl-pyrrolidin-3-ons
DE69902242D1 (de) Verfahren zur herstellung eines brotaufstrichs
DE50001155D1 (de) Verfahren zur Herstellung eines Stutzens
DE69934643D1 (de) Verfahren zur herstellung eines einkristalls mit halbleitender zusammensetzung
DE69921914D1 (de) Verfahren zur herstellung eines uhrengehäuses
DE69907496D1 (de) Verfahren zur herstellung eines formteils
DE69810815D1 (de) Verfahren zur herstellung eines ketimins
DE60000033T2 (de) Verfahren zur Herstellung eines Sol-Gel-Artikels
DE60042613D1 (de) Verfahren zur herstellung eines polyacetalcopolymers
DE69907854D1 (de) Verfahren zur Herstellung eines Entfeuchtungselements
DE69827326D1 (de) Verfahren zur Herstellung eines bandförmigen Gegenstandes
DE69928097D1 (de) Verfahren zur herstellung eines proteinhydrolysates
DE69822977D1 (de) Verfahren zur Herstellung eines Formkörpers
DE60024494D1 (de) Verfahren zur herstellung eines mentruationstampons
DE50003834D1 (de) Verfahren zur herstellung eines katalysators
DE50015309D1 (de) Verfahren zur herstellung eines kontakthöckers
DE60027056D1 (de) Verfahren zur Herstellung aliphatischer Fluoroformiate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition